Related Experiment Video
Updated: Jan 3, 2026
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro
Saied Mirshahidi1,2, Rosalia de Necochea-Campion1, Annie Moretta1
1Biospecimen Laboratory, Loma Linda University Cancer Center, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Abstract:
Recurrence or metastasis remains the major cause of poor prognosis and mortality in Osteosarcoma patients. Therefore, development of more effective therapeutic approaches is required. We showed that indomethacin, significantly induces apoptosis in MNNG/HOS cell line, which was confirmed by morphological changes, increased Annexin-V + cells and nuclear fragmentation. Apoptosis was accompanied by increased cleavage of caspase-3 and PARP, suggesting activation of caspase-dependent cell death. Indomethacin significantly decreased the expression of β-catenin, a key player in tumor metastasis. These results indicate that indomethacin may have the potential to be used as neoadjuvant or adjuvant treatment; however, additional studies are required.
Insights
Indomethacin induces apoptosis in osteosarcoma cells by activating caspase-dependent cell death and reducing tumor metastasis. This suggests potential as a neoadjuvant or adjuvant therapy for osteosarcoma.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Osteosarcoma recurrence and metastasis significantly contribute to poor patient prognosis and mortality.
- Effective therapeutic strategies are crucial to improve outcomes for osteosarcoma patients.
Purpose of the Study:
- To investigate the therapeutic potential of indomethacin in osteosarcoma.
- To elucidate the mechanisms underlying indomethacin's effects on osteosarcoma cells.
Main Methods:
- Utilized the MNNG/HOS osteosarcoma cell line.
- Assessed apoptosis via morphological changes, Annexin-V staining, and nuclear fragmentation.
- Measured caspase-3 and PARP cleavage to confirm caspase-dependent apoptosis.
- Quantified the expression of beta-catenin to evaluate its role in metastasis.
Main Results:
- Indomethacin significantly induced apoptosis in MNNG/HOS cells.
- Apoptosis was confirmed through caspase-dependent pathways, evidenced by increased caspase-3 and PARP cleavage.
- Indomethacin treatment led to a significant decrease in beta-catenin expression, a key factor in tumor metastasis.
Conclusions:
- Indomethacin demonstrates potential as an anti-cancer agent against osteosarcoma by inducing apoptosis and inhibiting metastasis.
- The drug's ability to reduce beta-catenin expression suggests a mechanism for its anti-metastatic effects.
- Further research is warranted to explore indomethacin's efficacy as a neoadjuvant or adjuvant therapy in clinical settings.
